The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors
This is the first national real-world evidence report on RLT for NET in Poland. The Registry provides unique insight into patient characteristics and clinical practice in the early phase of therapy implementation. Collected data will serve as a basis for the development of national recommendations and optimization of NET management.
Authors
- Katarzyna Jóźwik−Plebanek (ORCID: https://orcid.org/0000-0002-6756-5415)
- Beata Kos‐Kudła (ORCID: https://orcid.org/0000-0003-3755-1722)
- Marek A. Ruchała (ORCID: https://orcid.org/0000-0001-9743-2405)
- Violetta Rosiek (ORCID: https://orcid.org/0000-0002-5238-9287)
- Renata Świątkowska−Stodulska (ORCID: https://orcid.org/0000-0003-4633-2863)
- Daria Handkiewicz-Junak (ORCID: https://orcid.org/0000-0003-0802-2880)
- Anhelli Syrenicz (ORCID: https://orcid.org/0000-0002-7302-4404)
- Karol Piotr Sagan (ORCID: https://orcid.org/0000-0003-1918-4519)
- Maciej Kołodziej (ORCID: https://orcid.org/0000-0003-1943-264X)
- Anna Lewczuk-Myślicka
- Grzegorz Kamiński (ORCID: https://orcid.org/0000-0002-2357-0634)
- Jan Musiłkiewcz
- Aleksandra Ledown
Institutions
- Poznan University of Medical Sciences (PL)
- National Academy of Medicine (US)
- Medical University of Silesia (PL)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Gdańsk Medical University (PL)
- Pomeranian Medical University (PL)
Publication Details
- Journal
- Nuclear Medicine Review
- Published
- 2025-03-10
- DOI
- https://doi.org/10.5603/nmr.108401
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00